Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Jun 3;7(9):950–957. doi: 10.1158/1940-6207.CAPR-14-0075

Table 4. Effect of genotype at rs11781886 and rs2228013 on total prostate cancer risk in each intervention arm of the SELECT case-control cohort.

Genotype Intervention arm
Placebo
N = 1220
Vitamin E
N = 1318
Selenium
N = 1247
Vitamin E + Selenium N = 1216
rs11781886 HR 95% CI p value HR 95% CI p value HR 95% CI p value HR 95% CI p value
TT 1.000 Ref Ref 1.142 0.891-1.463 0.2951 1.074 0.836-1.379 0.5753 1.218 0.947-1.567 0.1238
CT 1.175 0.895-1.542 0.2448 1.500 1.124-1.971 0.0036 1.218 0.918-1.617 0.1710 0.966 0.733-1.272 0.8048
CC 1.144 0.690-1.898 0.6015 1.233 0.744-2.042 0.4162 1.676 1.011-2.777 0.0450 0.987 0.541-1.803 0.9671
p trend 0.2897 0.8548 0.6457 0.0634
rs2228013
GG 1.000 Ref Ref 1.165 0.968-1.403 0.1066 1.064 0.882-1.283 0.5191 1.037 0.859-1.252 0.7074
AG or AA 0.912 0.574-1.447 0.6952 1.137 0.742-1.740 0.5557 1.365 0.876-2.128 0.1685 0.740 0.456-1.203 0.2247
p trend 0.6952 0.8330 0.2934 0.4722